Search

Your search keyword '"Ciferri, G"' showing total 8 results
Start Over Author "Ciferri, G"
8 results on '"Ciferri, G"'

1. Reducing the occupational risk of infections for the surgeons: multicentricnational survey on the more than 15,00 surgical procedures

Author

Merigliano, Stefano, Pietrabissa, A., Montorsi, M., Poggioli, G., and Doglietto, M. STELLA D. BORZOMANTI E. CIFERRI G. R. O. S. S. I. G. B.

Subjects
OPERATIONS, GLOVES, PRACTICING SURGEON, HUMAN-IMMUNODEFICIENCY-VIRUS, HIV-INFECTION, PRACTICING SURGEON, INJURIES, TRANSMISSION, PRECAUTIONS, OPERATIONS, GLOVES, HIV-INFECTION, TRANSMISSION, HUMAN-IMMUNODEFICIENCY-VIRUS, INJURIES, PRECAUTIONS
Published
1997

2. Sobrerol in the Treatment of Secretory Otitis Media in Childhood

Author

Bellussi, L., Bernocchi, D., Ciferri, G., Manini, G., and Passali, D.

Abstract

The therapeutic activity and tolerability of sobrerol, a muco-active agent, were evaluated in 30 children (aged 5–10 years) with secretory otitis media. The drug was administered once daily by inhalation for 10 days consecutively at a dose of 40 mg/3 ml. Clinical assessments showed a significant improvement in the objective measures together with good tolerability. Moreover, sobrerol was shown to improve impedance values; this is an important aspect of the modifications induced by this drug in diseases involving the ear.

Published
1989
Full Text
View/download PDF

7. [Use of nimesulide in inflammations of the upper respiratory tract].

Author

Passàli D, Bellussi L, Ciferri G, and Scaricabarozzi I

Subjects
Adolescent, Adult, Aged, Drug Evaluation, Female, Humans, Male, Middle Aged, Pharyngitis drug therapy, Rhinitis drug therapy, Sinusitis drug therapy, Tonsillitis drug therapy, Anti-Inflammatory Agents, Non-Steroidal therapeutic use, Feprazone therapeutic use, Phenylbutazone analogs & derivatives, Respiratory Tract Infections drug therapy, Sulfonamides therapeutic use
Abstract

In a controlled clinical study of 40 patients, aged 18 to 65, suffering from acute inflammatory pathology of the upper respiratory tract or from a chronic form flaring into acute crisis, without any general symptoms of infection, were assigned at random to treatment with nimesulide in tablet form (100 mg x 2/day), or with phenylprenazone in capsules (200 mg x 2/day) for a period of seven days. In both groups a clinically significant reduction of the symptoms was obtained (congestion and edema of the pharyngeal mucosa, cough) as well as an improvement in the values of conductance and MCTt. Epigastralgy was evidenced in three subjects treated with nimesulide and in four treated with phenylprenazone. No significant variations of the laboratory parameters were found in either treatment group.

Published
1989

8. [Use of trace elements in therapy of secretory otitis media; preliminary results].

Author

Passàli D, De Seta E, Ciferri G, and Bianchini-Ciampoli M

Subjects
Adolescent, Child, Copper therapeutic use, Female, Humans, Male, Manganese therapeutic use, Anti-Inflammatory Agents therapeutic use, Expectorants therapeutic use, Otitis Media drug therapy, Otitis Media with Effusion drug therapy, Trace Elements therapeutic use
Published
1983

Catalog

Books, media, physical & digital resources
See catalog results